🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsCost comparison: oral vs injectable semaglutide — 12 month update Page 4

Cost comparison: oral vs injectable semaglutide — 12 month update

ben_calgary Mon, Oct 20, 2025 at 7:53 AM 23 replies 1,361 viewsPage 4 of 5
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Oct 21, 2025 at 7:25 AM#16

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

43 18pam_stl, wei_SG, cory_ATX and 40 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Oct 21, 2025 at 10:33 AM#17
LabKate said:
One practical note: write down what you did and when, before you need it.

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

42 17BrianDallas92, labquiet_amy, emily_PDX and 39 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Oct 21, 2025 at 1:41 PM#18

Adding the numbers, since they settle part of this. The mechanism that matters here is not stomach emptying, it is central. GLP-1 receptor agonism in the arcuate nucleus stimulates POMC neurons and suppresses AgRP/NPY signalling, which is why the effect is appetite and food salience rather than physical fullness. Delayed gastric emptying largely tachyphylaxes over the first months; the appetite effect does not.

41 16FranDenver, Dr.BariatricHTX, LindaRN_retired and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SkepticalSean
Member
98
345
Jan 2025
Maine
Oct 21, 2025 at 4:49 PM#19

A narrower follow-up, since the general answer is now clear:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

40 15tammy_FL, Dr.LipidDallas, alex_tucson and 37 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Oct 21, 2025 at 7:57 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

Last edited: Oct 21, 2025 at 10:57 PM
18 18kate.chem, DataDave, Dr.GutHealth and 15 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register